News Releases
News Releases

Lumentum Announces Fiscal Fourth Quarter And Full Year 2018 Results

08/08/2018

Achieved record Net revenue of $1.25 billion, up 25% relative to the prior year, and record profitability for fiscal year 2018
Fiscal Fourth Quarter Highlights:
- Net revenue of $301.1 million
- GAAP Operating margin of 6.9%; Non-GAAP Operating margin of 17.8%
- GAAP diluted Net income per common share of $0.40; Non-GAAP diluted Net income per share of $0.95

MILPITAS, Calif., Aug. 8, 2018 /PRNewswire/ -- Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fiscal fourth quarter and full year ended June 30, 2018.

Net revenue for the fiscal fourth quarter 2018 was $301.1 million, with GAAP net income attributable to common stockholders of $25.7 million, or $0.40 per diluted share. Net revenue for fiscal third quarter 2018 was $298.8 million, with GAAP net income attributable to common stockholders of $2.4 million, or $0.04 per diluted share. Net revenue for the fiscal fourth quarter 2017 was $222.7 million, with GAAP net loss attributable to common stockholders of $(55.2) million, or $(0.90) per diluted share.

Non-GAAP net income for the fiscal fourth quarter 2018 was $61.6 million, or $0.95 per diluted share. Non-GAAP net income for fiscal third quarter 2018 was $50.6 million, or $0.78 per diluted share. Non-GAAP net income for the fiscal fourth quarter 2017 was $25.0 million, or $0.39 per diluted share.

The Company held $711.5 million in total cash and short-term investments at the end of the fiscal fourth quarter 2018.

Net revenue for fiscal year 2018 was $1,247.7 million, with GAAP net income attributable to common stockholders of $241.5 million, or $3.82 per diluted share. Net revenue for fiscal year 2017 was $1,001.6 million, with GAAP net loss attributable to common stockholders of $(103.4) million, or $(1.71) per diluted share.

Non-GAAP net income for fiscal year 2018 was $247.8 million or $3.82 per diluted share. Non-GAAP net income for fiscal year 2017 was $122.4 million, or $1.94 per diluted share.

"Record revenues in TrueFlex® ROADMs, commercial lasers, and industrial pump lasers drove strong fourth quarter results, capping off a record fiscal 2018 that saw 25% year over year growth and 19.7% operating margins," said Alan Lowe, President and CEO, "Our strategy of investing in differentiated products addressing multiple growing end-markets critically dependent on photonics drove our strong fiscal 2018 results and positions us well for the future."

Financial Overview – Fiscal Fourth Quarter Ended June 30, 2018

 

GAAP Results ($ in millions)

 

Q4

 

Q3

 

Q4

 

Change

 

FY 2018

 

FY 2018

 

FY 2017

 

Q/Q

 

Y/Y

Net revenue

$301.1

 

$298.8

 

$222.7

 

0.8%

 

35.2%

Gross margin

31.7%

 

32.5%

 

30.2%

 

(80)bps

 

150bps

Operating margin

6.9%

 

8.5%

 

1.8%

 

(160)bps

 

510bps

                   
 

Non-GAAP Results ($ in millions)

 

Q4

 

Q3

 

Q4

 

Change

 

FY 2018

 

FY 2018

 

FY 2017

 

Q/Q

 

Y/Y

Net revenue

$301.1

 

$298.8

 

$222.7

 

0.8%

 

35.2%

Gross margin

37.2%

 

36.3%

 

32.9%

 

90bps

 

430bps

Operating margin

17.8%

 

16.5%

 

9.2%

 

130bps

 

860bps

                   

 

 

Net Revenue by Segment ($ in millions)

 

Q4

 

% of

 

Q3

 

Q4

 

Change

 

FY 2018

 

Net Revenue

 

FY 2018

 

FY 2017

 

Q/Q

 

Y/Y

Optical Communications

$244.9

 

81.3%

 

$246.3

 

$186.8

 

(0.6)%

 

31.1%

Lasers

56.2

 

18.7%

 

52.5

 

35.9

 

7.0%

 

56.5%

Total

$301.1

 

100.0%

 

$298.8

 

$222.7

 

0.8%

 

35.2%

                       

Financial Overview – Fiscal Year Ended June 30, 2018

 

GAAP Results ($ in millions)

 

FY 2018

 

FY 2017

 

Change Y/Y

 

Net revenue

$1,247.7

 

$1,001.6

 

24.6%

 

Gross margin

34.6%

 

31.8%

 

280bps

 

Operating margin

11.2%

 

4.8%

 

640bps

 
             
 

Non-GAAP Results ($ in millions)

 

FY 2018

 

FY 2017

 

Change Y/Y

 

Net revenue

$1,247.7

 

$1,001.6

 

24.6%

 

Gross margin

38.9%

 

34.7%

 

420bps

 

Operating margin

19.7%

 

12.4%

 

730bps

 
             
 

Net Revenue by Segment ($ in millions)

 

FY 2018

 

FY 2017

 

Change Y/Y

 

Optical Communications

$1,059.2

 

$857.8

 

23.5%

 

Lasers

188.5

 

143.8

 

31.1%

 

Total

$1,247.7

 

$1,001.6

 

24.6%

 
             

The tables above provide comparisons of quarterly and annual results to prior periods, including sequential quarterly and year-over-year changes. A reconciliation between GAAP and non-GAAP measures is contained in this release under the section titled "Use of Non-GAAP Financial Measures."

Business Outlook

The Company expects the following for the fiscal first quarter 2019:

  • Net Revenue to be in the range of $340 million to $360 million
  • Non-GAAP Operating margin of 19% to 21%
  • Non-GAAP diluted earnings per share of $0.90 to $1.10

Note:  Earnings per share based on approximately 65.5 million shares outstanding on a fully diluted basis

Our projection of 65.5 million shares outstanding does not include the potentially dilutive effect of the convertible notes, as we have the ability and intent to settle the face value in cash; and therefore, we use the treasury stock method for calculating the dilutive impact of the 2024 Notes. The notes will have an impact on our diluted earnings per share when the average price of our common stock exceeds the conversion price of $60.62. Our guidance does not include results from Oclaro or shares issued in connection with the closing of our acquisition of Oclaro as we are unable to predict the timing of the closing.

We have not provided reconciliations from GAAP to non-GAAP measures for our outlook. A large portion of non-GAAP adjustments, such as derivative liability adjustments, restructuring charges, stock-based compensation, litigation, acquisition related costs, non-cash income tax expense and credits, and other costs and contingencies unrelated to current and future operations are by their nature highly volatile and we have low visibility as to the range that may be incurred in the future. For example, in the fiscal second quarter of 2018, we had a credit of $207.0 million primarily related to a release of a U.S. valuation allowance, which was offset by a write-down of deferred tax assets in the amount of $83.0 million due to the lower corporate tax rate enacted under the 2017 "Tax Cuts and Jobs Act" reform.

Conference Call

Lumentum will host a conference call on August 8, 2018 at 5:30 am PT/8:30 am ET. A live webcast of the call and the replay will be available on the Lumentum website at http://investor.lumentum.com through August 15, 2018 at 11:59 pm ET. Supporting materials outlining the Company's latest financial results will be posted on http://investor.lumentum.com under the "Events and Presentations" section concurrently with this earnings press release. This press release is being furnished as an exhibit to a Current Report on Form 8-K with the Securities and Exchange Commission and will be available at http://www.sec.gov/.

About Lumentum

Lumentum (NASDAQ: LITE) is a market-leading manufacturer of innovative optical and photonic products enabling optical networking and commercial laser customers worldwide. Lumentum's optical components and subsystems are part of virtually every type of telecom, enterprise, and data center network. Lumentum's commercial lasers enable advanced manufacturing techniques and diverse applications including next-generation 3D sensing capabilities. Lumentum is headquartered in Milpitas, California with R&D, manufacturing, and sales offices worldwide. For more information, visit https://www.lumentum.com/en.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements include our expectations for our markets, including future product shipments and associated revenue, any anticipation or guidance as to future financial performance, including future net revenue, earnings per share, and operating margins, number of outstanding shares, our proposed acquisition of Oclaro, including the anticipated closing date, our investment strategy, and anticipated trends in our markets. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected. Among the factors that could cause actual results to differ from those contemplated are: (a) quarter-over-quarter product mix fluctuations which can materially impact profitability measures due to the broad gross margin ranges across our portfolio; (b) continued decline of average selling prices across our businesses; (c) effects of seasonality; (d) the ability of our suppliers and contract manufacturers to meet production and delivery requirements to our forecasted demand; (e) inherent uncertainty related to global markets and the effect of such markets on demand for our products; (f) changes in customer demand; (g) our ability to attract and retain new customers, particularly in the 3D sensing market; (h) the risk that the Oclaro transaction does not close, due to the failure of one or more conditions to closing or the failure of the businesses (including personnel) to be integrated successfully after closing; (i) the risk that synergies and non-GAAP earnings accretion will not be realized or realized to the extent anticipated; (j) uncertainty as to the market value of the Lumentum merger consideration to be paid in the merger; (k) the risk that required governmental approvals of the merger (including China antitrust approvals) will not be obtained or that such approvals will be delayed beyond current expectations; (l) the risk that following this transaction, Lumentum's financing or operating strategies will not be successful; (m) litigation in respect of either company or the merger; and (n) disruption from the merger making it more difficult to maintain customer, supplier, key personnel and other strategic relationships. For more information on these and other risks, please refer to the "Risk Factors" section included in the Company's Quarterly Report on Form 10-Q for the fiscal third quarter ended March 31, 2018 filed with the Securities and Exchange Commission, in the S-4 filed by Lumentum with the Securities and Exchange Commission on May 17, 2018, as amended on May 31, 2018, in connection with the Oclaro transaction and in the documents which are incorporated by reference therein, and in the Company's other filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2018 which will be filed within sixty days of our fiscal year end. The forward-looking statements and preliminary financial results contained in this press release are made as of the date hereof and the Company assumes no obligation to update such statements, except as required by applicable law.

No Offer or Solicitation

This communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

Additional Information and Where to Find It

In connection with the proposed transaction between Lumentum Holdings, Inc. ("Lumentum") and Oclaro, Inc. ("Oclaro"), Lumentum filed a registration statement on Form S-4 with the Securities and Exchange Commission (the "SEC"), which includes a proxy statement of Oclaro that also constitutes a prospectus of Lumentum. The registration statement was declared effective by the SEC on May 31, 2018, and Oclaro commenced mailing the definitive joint proxy statement/prospectus to stockholders of Oclaro on or about June 4, 2018, and the special meeting of the stockholders of Oclaro was held on July 10, 2018.

LUMENTUM AND OCLARO URGE INVESTORS AND SECURITY HOLDERS TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

Investors and security holders may obtain these materials and other documents filed with the Securities and Exchange Commission free of charge at the Securities and Exchange Commission's website, www.sec.gov. Copies of documents filed with the Securities and Exchange Commission by Lumentum (when they become available) may be obtained free of charge on Lumentum's website at www.lumentum.com or by directing a written request to Lumentum Holdings Inc., Investor Relations, 400 North McCarthy Boulevard, Milpitas, CA 95035. Copies of documents filed with the Securities and Exchange Commission by Oclaro (when they become available) may be obtained free of charge on Oclaro's website at www.oclaro.com or by directing a written request to Oclaro, Inc. Investor Relations, 225 Charcot Avenue, San Jose, CA 95131.

Contact Information

Investors: Chris Coldren, 408-404-0606; investor.relations@lumentum.com
Press: Greg Kaufman, 408-546-4593; media@lumentum.com

The following financial tables are presented in accordance with GAAP, unless otherwise specified.

LUMENTUM HOLDINGS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)

(unaudited)

 
 

Three Months Ended

 

Twelve Months Ended

 

June 30, 2018

 

July 1, 2017

 

June 30, 2018

 

July 1, 2017

Net revenue

$

301.1

   

$

222.7

   

$

1,247.7

   

$

1,001.6

 

Cost of sales

204.8

   

154.0

   

812.4

   

677.0

 

Amortization of acquired developed technologies

0.8

   

1.4

   

3.2

   

6.5

 

Gross profit

95.5

   

67.3

   

432.1

   

318.1

 

Operating expenses:

             

    Research and development

38.5

   

35.4

   

156.8

   

148.3

 

    Selling, general and administrative

32.7

   

26.0

   

128.2

   

110.2

 

    Restructuring and related charges

3.4

   

2.0

   

7.2

   

12.0

 

Total operating expenses

74.6

   

63.4

   

292.2

   

270.5

 

Income from operations

20.9

   

3.9

   

139.9

   

47.6

 

Unrealized gain (loss) on derivative liabilities

7.8

   

(29.7)

   

(0.8)

   

(104.2)

 

Interest and other (expense) income, net

(1.0)

   

(1.8)

   

(9.7)

   

(3.2)

 

Income (loss) before income taxes

27.7

   

(27.6)

   

129.4

   

(59.8)

 

Provision for (benefit from) income taxes

(5.8)

   

27.3

   

(118.7)

   

42.7

 

Net income (loss)

33.5

   

(54.9)

   

248.1

   

(102.5)

 
               

Items reconciling net income (loss) to net income (loss) attributable to common stockholders:

             

Cumulative dividends on Series A Preferred Stock

(0.2)

   

(0.3)

   

(0.9)

   

(0.9)

 

Earnings allocated to Series A Preferred Stock

(0.8)

   

$

   

(5.7)

   

$

 

Net income (loss) attributable to common stockholders - Basic

$

32.5

   

$

(55.2)

   

$

241.5

   

$

(103.4)

 

 Add: Earnings allocated to Series A Preferred Stock

0.8

   

   

   

 

 Add/Less: Unrealized (gain) loss on derivative liability on Series A Preferred Stock

(7.8)

   

   

   

 

 Add: Cumulative dividends on Series A Preferred Stock

0.2

   

   

   

 

Net income (loss) attributable to common stockholders - Diluted (a)

$

25.7

   

$

(55.2)

   

$

241.5

   

$

(103.4)

 
               

Net income (loss) per share attributable to common stockholders:

             

Basic

$

0.52

   

$

(0.90)

   

$

3.88

   

$

(1.71)

 

Diluted

$

0.40

   

$

(0.90)

   

$

3.82

   

$

(1.71)

 
               

Shares used to compute net income (loss) per share attributable to common stockholders:

             

Basic

62.7

   

61.3

   

62.3

   

60.6

 

Diluted

65.0

   

61.3

   

63.3

   

60.6

 
 

(a) For the three months ended June 30, 2018, our diluted earnings per share attributable to common stockholders is calculated using the "if-converted" method because it is more dilutive, whereas for the twelve months ended June 30, 2018, our diluted earnings per share attributable to common stockholders is calculated using "two-class" method.

 

LUMENTUM HOLDINGS INC.

CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

(unaudited)

 
 

June 30, 2018

 

July 1, 2017

ASSETS

     

Current assets:

     

Cash and cash equivalents

$

397.3

   

$

272.9

 

Short-term investments

314.2

   

282.4

 

Accounts receivable, net

197.1

   

166.3

 

Inventories

153.6

   

145.2

 

Prepayments and other current assets

65.0

   

63.5

 

Total current assets

1,127.2

   

930.3

 

Property, plant and equipment, net

306.9

   

273.5

 

Goodwill and intangibles, net

18.3

   

21.5

 

Deferred income taxes, net

125.6

   

3.9

 

Other non-current assets

3.5

   

3.7

 

Total assets

$

1,581.5

   

$

1,232.9

 

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY

     

Current liabilities:

     

Accounts payable

$

126.5

   

$

114.8

 

Accrued payroll and related expenses

31.5

   

27.5

 

Accrued expenses

33.9

   

19.3

 

Other current liabilities

22.1

   

22.6

 

     Total current liabilities

214.0

   

184.2

 

Convertible notes

334.2

   

317.5

 

Derivative liability

52.4

   

51.6

 

Other non-current liabilities

19.0

   

25.0

 

Total liabilities

619.6

   

578.3

 
       

Redeemable convertible preferred stock:

     

Non-controlling interest redeemable convertible Series A Preferred Stock, $0.001 par value, 10,000,000 authorized shares; 35,805 shares issued and outstanding as of June 30, 2018 and July 1, 2017

35.8

   

35.8

 

     Total redeemable convertible preferred stock

35.8

   

35.8

 

Stockholders' equity:

     

Common stock, $0.001 par value, 990,000,000 authorized shares, 62,790,087 and 61,476,103 shares issued and outstanding as of June 30, 2018 and July 1, 2017, respectively

0.1

   

0.1

 

Additional paid-in capital

753.2

   

694.5

 

Retained earnings

166.4

   

(83.2)

 

Accumulated other comprehensive income

6.4

   

7.4

 

Total stockholders' equity

926.1

   

618.8

 

Total liabilities, redeemable convertible preferred stock, and stockholders' equity

$

1,581.5

   

$

1,232.9

 

Use of Non-GAAP Financial Measures

In this press release, Lumentum provides investors with gross margin, operating margin, net income, and net income (loss) per share on a non-GAAP basis. Lumentum believes this non-GAAP financial information provides additional insight into the Company's on-going performance and has therefore chosen to provide this information to investors for a more consistent basis of comparison and to help them evaluate the results of the Company's on-going operations and enable more meaningful period to period comparisons. Specifically, the Company believes that providing this information allows investors to better understand the Company's financial performance and, importantly, to evaluate the efficacy of the methodology and information used by management to evaluate and measure such operating performance.  However, these measures may be different from non-GAAP measures used by other companies, limiting their usefulness for comparison purposes. The non-GAAP financial measures used in this press release should not be considered in isolation from measures of financial performance prepared in accordance with GAAP. Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. In particular, many of the adjustments to our GAAP financial measures reflect the exclusion of items that are recurring and will be reflected in our financial results for the foreseeable future. Further, these non-GAAP financial measures may not be comparable to similarly titled measurements reported by other companies.

Non-GAAP gross margin, non-GAAP operating margin, non-GAAP net income, and non-GAAP net income per share, Adjusted EBITDA, non-GAAP gross profit, non-GAAP operating income, non-GAAP income (loss) before income taxes and non-GAAP expenses exclude (i) stock-based compensation,(ii) acquisition related costs, (iii) other charges comprised mainly of set-up costs of our Thailand facility, including costs of transferring product lines to Thailand, as well as inventory write-downs due to cancelled programs and other costs and contingencies unrelated to current and future operations, (iv) amortization of acquired developed technologies, (v) workforce related charges such as severance, retention bonuses and employee relocation costs related to formal restructuring plans, (vi) non-cash interest expense, (vii) unrealized gain (loss) on derivative liability, (viii) non-cash income tax provision impacts, for example, a release of a U.S. valuation allowance, and the write down of deferred tax assets due to the 2017 Tax Cuts and Jobs Act. The presentation of these and other similar items in Lumentum's non-GAAP financial results should not be interpreted as implying that these items are non-recurring, infrequent or unusual.

A quantitative reconciliation between GAAP and non-GAAP financial data with respect to historical periods is included in the supplemental financial table attached to this press release.

LUMENTUM HOLDINGS INC.

RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES

(in millions, except per share data)

(unaudited)

 
 

Three Months Ended

 

Twelve Months Ended

 

June 30, 2018

 

July 1, 2017

 

June 30, 2018

 

July 1, 2017

               

Gross profit on GAAP basis

$

95.5

   

$

67.3

   

$

432.1

   

$

318.1

 

Stock-based compensation

3.1

   

1.5

   

12.6

   

7.5

 

Other charges related to non-recurring activities (a)

12.7

   

3.0

   

37.2

   

15.1

 

Amortization of acquired developed technologies

0.8

   

1.4

   

3.2

   

6.5

 

Gross profit on non-GAAP basis

$

112.1

   

$

73.2

   

$

485.1

   

$

347.2

 
               

Research and development on GAAP basis

$

38.5

   

$

35.4

   

$

156.8

   

$

148.3

 

Stock-based compensation

(3.7)

   

(2.8)

   

(14.2)

   

(11.6)

 

Other charges related to non-recurring activities

(0.6)

   

(0.3)

   

(2.0)

   

(1.0)

 

Research and development on non-GAAP basis

$

34.2

   

$

32.3

   

$

140.6

   

$

135.7

 
               

Selling, general and administrative on GAAP basis

$

32.7

   

$

26.0

   

$

128.2

   

$

110.2

 

Stock-based compensation

(4.9)

   

(3.5)

   

(20.0)

   

(13.6)

 

Acquisition related costs

(2.1)

   

   

(4.8)

   

 

Other charges related to non-recurring activities

(1.4)

   

(2.0)

   

(5.1)

   

(9.1)

 

Amortization of acquired developed technologies

   

   

   

(0.3)

 

Selling, general and administrative on non-GAAP basis

$

24.3

   

$

20.5

   

$

98.3

   

$

87.2

 
               

Income from operations on GAAP basis

$

20.9

   

$

3.9

   

$

139.9

   

$

47.6

 

Stock-based compensation

11.7

   

7.8

   

46.8

   

32.7

 

Acquisition related costs

2.1

   

   

4.8

   

 

Other charges related to non-recurring activities (a)

14.7

   

5.3

   

44.3

   

25.2

 

Amortization of acquired developed technologies

0.8

   

1.4

   

3.2

   

6.8

 

Restructuring and related charges

3.4

   

2.0

   

7.2

   

12.0

 

Income from operations on non-GAAP basis

$

53.6

   

$

20.4

   

$

246.2

   

$

124.3

 
               

Interest and other (expense) income, net on GAAP basis

$

(1.0)

   

$

(1.8)

   

$

(9.7)

   

$

(3.2)

 

Non-cash other (income) expense

   

(1.4)

   

(0.1)

   

(1.7)

 

Effective interest expense on convertible notes

4.3

   

4.1

   

16.7

   

5.1

 

Interest and other (expense) income, net on non-GAAP basis

$

3.3

   

$

0.9

   

$

6.9

   

$

0.2

 
               

Income (loss) before income taxes on GAAP basis

$

27.7

   

$

(27.6)

   

$

129.4

   

$

(59.8)

 

Stock-based compensation

11.7

   

7.8

   

46.8

   

32.7

 

Acquisition related costs

2.1

   

   

4.8

   

 

Other charges related to non-recurring activities (a)

14.7

   

5.3

   

44.3

   

25.2

 

Amortization of acquired developed technologies

0.8

   

1.4

   

3.2

   

6.8

 

Restructuring and related charges

3.4

   

2.0

   

7.2

   

12.0

 

Non-cash other (income) expense

   

(1.4)

   

(0.1)

   

(1.7)

 

Effective interest expense on convertible notes

4.3

   

4.1

   

16.7

   

5.1

 

Unrealized (gain) loss on derivative liabilities

(7.8)

   

29.7

   

0.8

   

104.2

 

Income before income taxes on non-GAAP basis

$

56.9

   

$

21.3

   

$

253.1

   

$

124.5

 
               

Provision for (benefit from) income taxes on GAAP basis

$

(5.8)

   

$

27.3

   

$

(118.7)

   

$

42.7

 

Income tax adjustments (b)

1.1

   

(31.0)

   

124.0

   

(40.6)

 

Provision for (benefit from) income taxes on non-GAAP basis

$

(4.7)

   

$

(3.7)

   

$

5.3

   

$

2.1

 
               

Net income (loss) on GAAP basis

$

33.5

   

$

(54.9)

   

$

248.1

   

$

(102.5)

 

Stock-based compensation

11.7

   

7.8

   

46.8

   

32.7

 

Acquisition related costs

2.1

   

   

4.8

   

 

Other charges related to non-recurring activities (a)

14.7

   

5.3

   

44.3

   

25.2

 

Amortization of acquired developed technologies

0.8

   

1.4

   

3.2

   

6.8

 

Restructuring and related charges

3.4

   

2.0

   

7.2

   

12.0

 

Non-cash other (income) expense

   

(1.4)

   

(0.1)

   

(1.7)

 

Effective interest expense on convertible notes

4.3

   

4.1

   

16.7

   

5.1

 

Unrealized (gain) loss on derivative liabilities

(7.8)

   

29.7

   

0.8

   

104.2

 

Income tax adjustments (b)

(1.1)

   

31.0

   

(124.0)

   

40.6

 

Net income on non-GAAP basis

$

61.6

   

$

25.0

   

$

247.8

   

$

122.4

 
               

Net income per share on non-GAAP basis

$

0.95

   

$

0.39

   

$

3.82

   

$

1.94

 
               

Shares used in per share calculation - diluted on GAAP basis

65.0

   

61.3

   

63.3

   

60.6

 

Non-GAAP adjustment (c)

   

1.0

   

   

1.0

 

Effect of diluted securities from Series A Preferred Stock(d)

   

1.5

   

1.5

   

1.5

 

Shares used in per share calculation - diluted on non-GAAP basis

65.0

   

63.8

   

64.8

   

63.1

 
 

(a) The increase during the fiscal year ended June 30, 2018 primarily relates to set-up costs of our Thailand facility, including costs of transferring product lines to Thailand, as well as inventory write-downs due to cancelled programs.

 

(b) The change during the fiscal year ended June 30, 2018 is primarily attributable to a credit of $207.0 million related to a release of a U.S. valuation allowance, which was offset by the write down of deferred tax assets due to the 2017 "Tax Cuts and Jobs Act" reform in the amount of $83.0 million.

 

(c) This adjustment represents weighted-average potentially dilutive securities from our stock-based benefit plans excluded from the computation of diluted net loss per share attributable to common stockholders on a GAAP basis because the effect would have been anti-dilutive. This adjustment amount is added for the computation of diluted net income per share on a non-GAAP basis as we had a net income on a non-GAAP basis.

 

(d) 1.5 million shares related to the potential conversion of the Series A Preferred Stock were added to the calculation of diluted shares available on a non-GAAP basis because their inclusion results in more dilutive earnings per share.

 

LUMENTUM HOLDINGS INC.

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA

(in millions)

(unaudited)

 
 

Three Months Ended

 

Twelve Months Ended

 

June 30, 2018

 

July 1, 2017

 

June 30, 2018

 

July 1, 2017

GAAP net income (loss)

$

33.5

   

$

(54.9)

   

$

248.1

   

$

(102.5)

 

Interest and other expense (income), net

1.0

   

1.8

   

9.7

   

3.2

 

Provision for (benefit from) income taxes (b)

(5.8)

   

27.3

   

(118.7)

   

42.7

 

Depreciation

20.7

   

15.1

   

74.0

   

54.2

 

Amortization of acquired developed technologies

0.8

   

1.4

   

3.2

   

6.8

 

EBITDA

50.2

   

(9.3)

   

216.3

   

4.4

 

Restructuring and related charges

3.4

   

2.0

   

7.2

   

12.0

 

Stock-based compensation

11.7

   

7.8

   

46.8

   

32.7

 

Acquisition related costs

2.1

   

   

4.8

   

 

Other charges related to non-recurring activities (a)

14.7

   

5.3

   

44.3

   

25.2

 

   Unrealized (gain) loss on derivative liabilities

(7.8)

   

29.7

   

0.8

   

104.2

 

Adjusted EBITDA

$

74.3

   

$

35.5

   

$

320.2

   

$

178.5

 
 

(a) The increase during the fiscal year ended June 30, 2018 primarily relates to set-up costs of our Thailand facility, including costs of transferring product lines to Thailand, as well as inventory write-downs due to cancelled programs.

 

(b) The change during the fiscal year ended June 30, 2018 is primarily attributable to a credit of $207.0 million related to a release of a U.S. valuation allowance, which was offset by the write down of deferred tax assets due to the 2017 "Tax Cuts and Jobs Act" reform in the amount of $83.0 million.

 

Cision View original content:http://www.prnewswire.com/news-releases/lumentum-announces-fiscal-fourth-quarter-and-full-year-2018-results-300693936.html

SOURCE Lumentum